273 related articles for article (PubMed ID: 26787691)
1. Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection.
Kip AE; Rosing H; Hillebrand MJ; Blesson S; Mengesha B; Diro E; Hailu A; Schellens JH; Beijnen JH; Dorlo TP
Antimicrob Agents Chemother; 2016 Apr; 60(4):2081-9. PubMed ID: 26787691
[TBL] [Abstract][Full Text] [Related]
2. Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples.
Kip AE; Kiers KC; Rosing H; Schellens JHM; Beijnen JH; Dorlo TPC
J Pharm Biomed Anal; 2017 Feb; 135():160-166. PubMed ID: 28033553
[TBL] [Abstract][Full Text] [Related]
3. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial.
Mbui J; Olobo J; Omollo R; Solomos A; Kip AE; Kirigi G; Sagaki P; Kimutai R; Were L; Omollo T; Egondi TW; Wasunna M; Alvar J; Dorlo TPC; Alves F
Clin Infect Dis; 2019 Apr; 68(9):1530-1538. PubMed ID: 30188978
[TBL] [Abstract][Full Text] [Related]
5. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
Faucher JF; Morquin D; Reynes J; Chirouze C; Hoen B; Le Moing V
Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
[TBL] [Abstract][Full Text] [Related]
6. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
Ritmeijer K; Dejenie A; Assefa Y; Hundie TB; Mesure J; Boots G; den Boer M; Davidson RN
Clin Infect Dis; 2006 Aug; 43(3):357-64. PubMed ID: 16804852
[TBL] [Abstract][Full Text] [Related]
7. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
Abongomera C; Diro E; de Lima Pereira A; Buyze J; Stille K; Ahmed F; van Griensven J; Ritmeijer K
PLoS Negl Trop Dis; 2018 May; 12(5):e0006527. PubMed ID: 29799869
[TBL] [Abstract][Full Text] [Related]
8. Pharmacovigilance of Miltefosine in Treatment of Visceral Leishmaniasis in Endemic Areas of Bihar, India.
Pandey K; Ravidas V; Siddiqui NA; Sinha SK; Verma RB; Singh TP; Dhariwal AC; Das Gupta RK; Das P
Am J Trop Med Hyg; 2016 Nov; 95(5):1100-1105. PubMed ID: 27645786
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography-tandem mass spectrometry.
Dorlo TP; Hillebrand MJ; Rosing H; Eggelte TA; de Vries PJ; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):55-62. PubMed ID: 18325856
[TBL] [Abstract][Full Text] [Related]
10. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
Koster RA; Alffenaar JW; Greijdanus B; Uges DR
Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
[TBL] [Abstract][Full Text] [Related]
11. Quantification of miltefosine in peripheral blood mononuclear cells by high-performance liquid chromatography-tandem mass spectrometry.
Kip AE; Rosing H; Hillebrand MJ; Castro MM; Gomez MA; Schellens JH; Beijnen JH; Dorlo TP
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():57-62. PubMed ID: 26160472
[TBL] [Abstract][Full Text] [Related]
12. Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV.
Adriaensen W; Cuypers B; Cordero CF; Mengasha B; Blesson S; Cnops L; Kaye PM; Alves F; Diro E; van Griensven J
EBioMedicine; 2020 May; 55():102748. PubMed ID: 32361248
[TBL] [Abstract][Full Text] [Related]
13. LC-coupled ESI MS for quantification of miltefosine in human and hamster plasma.
Jaiswal S; Sharma A; Shukla M; Lal J
Bioanalysis; 2016 Mar; 8(6):533-45. PubMed ID: 26915470
[TBL] [Abstract][Full Text] [Related]
14. Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients.
Troya J; Casquero A; Refoyo E; Fernández-Guerrero ML; Górgolas M
Scand J Infect Dis; 2008; 40(1):78-80. PubMed ID: 17852921
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
Diro E; Blesson S; Edwards T; Ritmeijer K; Fikre H; Admassu H; Kibret A; Ellis SJ; Bardonneau C; Zijlstra EE; Soipei P; Mutinda B; Omollo R; Kimutai R; Omwalo G; Wasunna M; Tadesse F; Alves F; Strub-Wourgaft N; Hailu A; Alexander N; Alvar J
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006988. PubMed ID: 30653490
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an HPLC-MS/MS method for the quantification of the anti-leishmanial drug miltefosine in human skin tissue.
Roseboom IC; Thijssen B; Rosing H; Alves F; Mondal D; Teunissen MBM; Beijnen JH; Dorlo TPC
J Pharm Biomed Anal; 2022 Jan; 207():114402. PubMed ID: 34634528
[TBL] [Abstract][Full Text] [Related]
17. Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain.
Rai K; Cuypers B; Bhattarai NR; Uranw S; Berg M; Ostyn B; Dujardin JC; Rijal S; Vanaerschot M
mBio; 2013 Oct; 4(5):e00611-13. PubMed ID: 24105765
[TBL] [Abstract][Full Text] [Related]
18. Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study.
Dorlo TPC; Kip AE; Younis BM; Ellis SJ; Alves F; Beijnen JH; Njenga S; Kirigi G; Hailu A; Olobo J; Musa AM; Balasegaram M; Wasunna M; Karlsson MO; Khalil EAG
J Antimicrob Chemother; 2017 Nov; 72(11):3131-3140. PubMed ID: 28961737
[TBL] [Abstract][Full Text] [Related]
19. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
[TBL] [Abstract][Full Text] [Related]
20. Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study.
Kip AE; Blesson S; Alves F; Wasunna M; Kimutai R; Menza P; Mengesha B; Beijnen JH; Hailu A; Diro E; Dorlo TPC
J Antimicrob Chemother; 2021 Apr; 76(5):1258-1268. PubMed ID: 33677546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
